(S (NP-SBJ-55 (NP-COOD (NP (NP (NN Susceptibility)) (PP (TO to) (NP (JJ natural) (NN killer) (NNS cells)))) (CC and) (NP (NP (JJ down) (NN regulation)) (PP (IN of) (NP (NN MHC) (NN class) (CD I) (NN expression))))) (PP (IN in) (NP (NN adenovirus) (CD 12) (VBN transformed) (NNS cells)))) (VP (VBP are) (VP (VBN regulated) (NP (-NONE- *-55)) (PP (IN by) (NP-LGS (JJ different) (NN E1A) (NNS domains))))) (. .))
(S (S-COOD (S (NP-SBJ (DT All) (JJ human) (NNS adenoviruses)) (VP (VBP transform) (NP (JJ rodent) (NNS cells)) (ADVP (FW in) (FW vitro)))) (, ,) (CC but) (S (NP-SBJ (NP (RB only) (NNS cells)) (VP (VBN transformed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (NNS serotypes)) (VP (VBG belonging) (PP (TO to) (NP (NNS subgroups) (NP-COOD (NP (NP (NN A)) (PRN (-LRB- -LRB-) (NP (NN Ad12)) (-RRB- -RRB-))) (CC and) (NP (NP (NN B)) (PRN (-LRB- -LRB-) (NP (NN Ad3)) (-RRB- -RRB-))))))))))) (VP (VBP are) (ADJP-PRD (JJ tumorigenic)) (PP (IN for) (NP (JJ immunocompetent) (NNS animals)))))) (. .))
(S (PP (IN In) (NP (DT these) (NNS cells))) (, ,) (NP-SBJ-56 (NP (DT the) (NN expression)) (PP (IN of) (NP (NN MHC-class) (CD I) (NNS antigens)))) (VP-COOD (VP (VBZ is) (VP (VBN repressed) (NP (-NONE- *-56)))) (CC and) (VP (MD might) (VP (VB allow) (S (NP-SBJ (PRP them)) (VP-COOD (VP (TO to) (VP (VB escape) (PP (IN from) (NP (NP (NN recognition)) (PP (IN by) (NP (NP (JJ cytotoxic) (NN T) (NNS lymphocytes)) (PRN (-LRB- -LRB-) (NP (NN CTL)) (-RRB- -RRB-)))))))) (CC and) (VP (TO to) (VP (VB develop) (PP (IN in) (NP (NN tumor)))))))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP-SBJ (DT these) (NN cell) (NNS lines)) (VP (VBP appear) (ADJP-PRD (JJ resistant) (PP (TO to) (NP (NP (NN lysis)) (PP (IN by) (NP (NP (NP (JJ natural) (NN killer)) (PRN (-LRB- -LRB-) (NP (NN NK)) (-RRB- -RRB-))) (NNS cells))))))) (. .))
(S (S (NP-SBJ (-NONE- *)) (VP (TO To) (VP (VB determine) (NP (NP (DT the) (NN E1A) (NN domain) (-LRB- -LRB-) (NNS s) (-RRB- -RRB-)) (ADJP (JJ responsible) (PP (IN for) (NP (DT these) (NNS properties)))))))) (NP-SBJ-57 (JJ several) (NN cell) (NNS lines)) (VP (VBD were) (VP (VBN created) (NP (-NONE- *-57)) (PP (IN by) (S (NP-SBJ (-NONE- *)) (NP (VBG transforming) (NP (NP (NP (NN baby) (NN rat) (NN kidney)) (PRN (-LRB- -LRB-) (NP (NN BRK)) (-RRB- -RRB-))) (NNS cells)) (PP (IN with) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (NP (NNS plasmids)) (VP (VBG expressing) (NP (JJ different) (NN (Ad12 Ad2)) (NN hybrid) (NN E1A) (NN gene) (NNS products)))))))))))) (. .))
(S (NP-SBJ-58 (DT The) (NN MHC) (NN class) (CD 1) (NN gene) (NN expression)) (VP (VBD was) (VP (VBN inhibited) (NP (-NONE- *-58)) (PP-COOD (PP (IN in) (NP (NP (NNS cells)) (VP (VBG expressing) (NP (DT the) (NN Ad12) (NN 13S) (NN mRNA) (NN product))))) (CC and) (PP (IN in) (NP (NP (NNS cells)) (VP (VBN transformed) (NP (-NONE- *)) (PP (IN with) (NP (NP (NN (Ad12 Ad2)) (NN hybrid) (NN E1A) (NN gene) (NN product)) (VP (VBG harboring) (NP (NP (DT the) (JJ C-terminal) (NN part)) (PP (IN of) (NP (NP (DT the) (NP (NP (VBN conserved) (NN region)) (PRN (-LRB- -LRB-) (NP (NN CR)) (-RRB- -RRB-))) (CD 3)) (PP (IN of) (NP (NN Ad12))))))))))))))) (. .))
(S (NP-SBJ-59 (NP (NN Susceptibility)) (PP (IN of) (NP (DT these) (VBN transformed) (NN cell) (NNS lines))) (PP (TO to) (NP (NN NK) (NNS cells)))) (VP (VBD was) (VP (VBN determined) (NP (-NONE- *-59)) (PP (IN by) (NP-LGS (JJ cytolytic) (NNS assays))))) (. .))
(S (NP-SBJ (NP (DT The) (NNS results)) (VP (VBD obtained) (NP (-NONE- *)))) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ-60 (CD two) (NN Ad12) (NN E1A) (NNS domains)) (VP (VBP are) (VP (VBN required) (NP (-NONE- *-60)) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB induce) (NP (NP (NN resistance)) (PP (IN of) (NP (DT the) (NN cell) (NNS lines))) (PP (TO to) (NP (NN NK) (NNS cells)))))))))))) (. .))
